Our goal is to develop nanostructured biosensors for high-throughput detection and point-of-care diagnostics in support of the smart treatment of tuberculosis. In conjunction with our diagnostic technologies is the development of smart therapeutics for tuberculosis.
Nano-biosensors are diagnostic tools that can provide rapid results, are highly sensitive, simple to use, inexpensive, and ... can be carried around in your pocket!
We do an integrated approach to nano-biosensor development: Preparation, functionalization, synthesis, design, fabrication, and validation of biosensor devices, including the synthesis of aptamers and nanoparticles, and validating these biosensors in cultured targets and sample matrices.
* Target: Mycobacterium tuberculosis
* Biomarker discovery
* Validation in biological matrices: sputum, serum, tissues